WallStreetZenWallStreetZen

NASDAQ: ERYP
Erytech Pharma Sa Stock

$0.87-0.07 (-7.45%)
Updated Jun 1, 2023
ERYP Price
$0.87
Fair Value Price
N/A
Market Cap
$27.11M
52 Week Low
$0.30
52 Week High
$1.47
P/E
-79.45x
P/B
1.09x
P/S
0.31x
PEG
N/A
Dividend Yield
N/A
Revenue
$32.98M
Earnings
-$242.55k
Gross Margin
100%
Operating Margin
5.35%
Profit Margin
-0.7%
Debt to Equity
0.95
Operating Cash Flow
-$34M
Beta
0.48
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ERYP Overview

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ERYP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ERYP is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ERYP is good value based on its book value relative to its share price (1.09x), compared to the US Biotechnology industry average (5.14x)
P/B vs Industry Valuation
ERYP is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ERYP due diligence checks available for Premium users.

Be the first to know about important ERYP news, forecast changes, insider trades & much more!

ERYP News

Valuation

ERYP fair value

Fair Value of ERYP stock based on Discounted Cash Flow (DCF)
Price
$0.87
Fair Value
$2.69
Undervalued by
67.66%
ERYP is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ERYP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-79.45x
Industry
11.46x
Market
52.37x

ERYP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.09x
Industry
5.14x
ERYP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ERYP's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ERYP's Earnings (EBIT) of $1.76M... subscribe to Premium to read more.
Interest Coverage Financials
ERYP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$48.7M
Liabilities
$23.7M
Debt to equity
0.95
ERYP's short-term assets ($45.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ERYP's short-term assets ($45.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ERYP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ERYP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
ERYP's operating cash flow (-$33.79M)... subscribe to Premium to read more.
Debt Coverage Financials

ERYP vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ERYP$27.11M-7.02%-79.45x1.09x
AXLA$27.04M-6.38%-0.34x37.20x
MTEM$26.60M+0.43%-0.44x-13.93x
ZIVO$26.38M+1.82%-3.04x-15.14x
PTN$26.16M-7.35%-0.78x2.73x

Erytech Pharma Sa Stock FAQ

What is Erytech Pharma Sa's quote symbol?

(NASDAQ: ERYP) Erytech Pharma Sa trades on the NASDAQ under the ticker symbol ERYP. Erytech Pharma Sa stock quotes can also be displayed as NASDAQ: ERYP.

If you're new to stock investing, here's how to buy Erytech Pharma Sa stock.

What is the 52 week high and low for Erytech Pharma Sa (NASDAQ: ERYP)?

(NASDAQ: ERYP) Erytech Pharma Sa's 52-week high was $1.47, and its 52-week low was $0.30. It is currently -40.63% from its 52-week high and 191.33% from its 52-week low.

How much is Erytech Pharma Sa stock worth today?

(NASDAQ: ERYP) Erytech Pharma Sa currently has 31,018,553 outstanding shares. With Erytech Pharma Sa stock trading at $0.87 per share, the total value of Erytech Pharma Sa stock (market capitalization) is $27.11M.

Erytech Pharma Sa stock was originally listed at a price of $24.75 in Nov 10, 2017. If you had invested in Erytech Pharma Sa stock at $24.75, your return over the last 5 years would have been -96.47%, for an annualized return of -48.76% (not including any dividends or dividend reinvestments).

How much is Erytech Pharma Sa's stock price per share?

(NASDAQ: ERYP) Erytech Pharma Sa stock price per share is $0.87 today (as of Jun 1, 2023).

What is Erytech Pharma Sa's Market Cap?

(NASDAQ: ERYP) Erytech Pharma Sa's market cap is $27.11M, as of Jun 3, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Erytech Pharma Sa's market cap is calculated by multiplying ERYP's current stock price of $0.87 by ERYP's total outstanding shares of 31,018,553.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.